Akari Therapeutics
AKTX
12 hedge funds and large institutions have $3.35M invested in Akari Therapeutics in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
8% less funds holding
Funds holding: 13 → 12 (-1)
19% less capital invested
Capital invested by funds: $4.15M → $3.35M (-$800K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFW
Omnia Family Wealth
Aventura,
Florida
|
+$25.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.75K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.79K |
| 4 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$1.39K |
| 5 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
+$1.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$73.8K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$34.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$22K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$18K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HP
1
Hikari Power
Tokyo,
Japan
| $2.17M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $656K | – | – | – |
|
|
OFW
3
Omnia Family Wealth
Aventura,
Florida
| $267K | +$25.1K | +18 | +8% |
|
|
4
Renaissance Technologies
New York
| $188K | -$73.8K | -53 | -25% |
|
|
5
HighTower Advisors
Chicago,
Illinois
| $24K | -$34.8K | -25 | -56% |
|
|
6
Envestnet Asset Management
Chicago,
Illinois
| $17K | +$2.79K | +2 | +15% |
|
|
7
UBS Group
Zurich,
Switzerland
| $8K | +$9.75K | +7 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $5K | – | – | – |
|
|
PCG
9
Private Capital Group
West Hartford,
Connecticut
| $4K | +$1.39K | +1 | +50% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$1.39K | +1 | New |
|
11
Morgan Stanley
New York
| $1K | – | – | – |
|
|
PFGIA
12
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| $1K | +$1.39K | +1 | New |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$22K | -16 | Closed |
|
|
OAM
14
Oxford Asset Management
Oxford,
United Kingdom
| – | -$18K | -13 | Closed |
|
|
15
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -1 | Closed |
|
AKTX Hedge Fund Activity: Q1 2020 in Review
12 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q1 2020, worth a combined $3.35M — down 19% from $4.15M a quarter earlier.
Fund positioning in AKTX was balanced in Q1 2020: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Omnia Family Wealth, adding an estimated $25.1K. The largest seller was Renaissance Technologies, cutting an estimated $73.8K.
- 12 institutional investors held Akari Therapeutics (AKTX) as of Q1 2020, down from 13 in Q4 2019.
- Funds reported $3.35M of Akari Therapeutics stock for Q1 2020, down 19% quarter-over-quarter.
- 3 funds opened new Akari Therapeutics positions in Q1 2020 and 3 closed out, a net change of 0 holders.
- The largest Akari Therapeutics buyer in Q1 2020 was Omnia Family Wealth, an estimated $25.1K added.
- The largest Akari Therapeutics seller in Q1 2020 was Renaissance Technologies, an estimated $73.8K sold.
Based on aggregated 13F filings for Q1 2020.